Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04432870 · ClinicalTrials.gov registry record

Patients' Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study

A clinical trial, sponsored by Massachusetts General Hospital.

Completed
Registry status
203
Enrollment target

NCT04432870: Completed study, sponsored by Massachusetts General Hospital.

NCT04432870 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 203 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04432870 has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
203 participants
Enrollment target

Study Summary

The study is a cross-sectional survey study targeting patients aged 45-75 who had their screening or surveillance colonoscopy postponed or delayed due to the COVID pandemic. Study staff will survey a random subsample of patients to assess anxiety, COVID risk tolerance, cancer worry, willingness to screen and barriers to screening colonoscopy, and preference for colonoscopy and alternative colon cancer screening options. Eligible patients will be sent a survey packet in the mail that will include a cover letter, an information sheet describing the study, an incentive, and the survey. The cover letter will include information for participants to opt-out if they desire. Patients will be asked to complete the survey and return it back to study staff. Consent is implied with return of the survey. For the study, staff plan to invite 300 patients and expect to receive 195 completed surveys. Analyses will examine whether COVID-19 has changed patients' interest in colon cancer screening and the strength of patients' preferences for colonoscopy and other approaches to colon cancer screening. It will then examine factors associated with positive and negative views on rescheduling colonoscopies such as anxiety, worry, and risk perceptions.

Primary Outcome

Item with 5-point response assessing whether COVID-19 has increased, decreased or not changed interest in colon cancer screening

Trial Details

FieldValue
Enrollment Target 203 participants
Start Date 2020-06-09
Est. Completion 2021-06-30
Massachusetts General Hospital

2,032 total trials

What the finished NCT04432870 record still lists

NCT04432870 is an observational study that tracks outcomes without assigning an intervention. The registered 203 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT04432870 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04432870 about?

NCT04432870 is a clinical study titled "Patients' Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study". The study is a cross-sectional survey study targeting patients aged 45-75 who had their screening or surveillance colonoscopy postponed or delayed due to the COVID pandemic. Study staff will survey a random subsample of patients to assess anxiety, COVID risk tolerance, cancer worry, willingness to s...

What is the current status of trial NCT04432870?

This trial is currently completed. The enrollment target is 203 participants. The study started on 2020-06-09. Estimated completion is 2021-06-30.

Who is sponsoring clinical trial NCT04432870?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05652686 · 203 participants · Phase 1

    A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

  • NCT06063122 · 203 participants · NA

    Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants

  • NCT07031245 · 203 participants · NA

    Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout

  • NCT03481010 · 204 participants · NA

    Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04432870, the US trial registry maintained by the National Library of Medicine. NCT04432870 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.